Je was op zoek naar: medicinalindustris (Deens - Engels)

den europæiske medicinalindustris sårbarhed
the vulnerability of the european pharmaceutical industry

denne gruppe, g10, blev nedsat for at undersøge den europæiske medicinalindustris konkurrenceevne med samtidig sikring af et højt sundhedsbeskyttelsesniveau.
this group, known as the "g10", was set up to examine the european pharmaceutical industry's competitivity while at the same time guaranteeing a high level of health protection.

medlemsstaterne vil desuden samarbejde til gavn for den europæiske medicinalindustris forskning og således også til gavn for borgernes sundhed, da disse kan blive helbredt i rette tid med de nye produkter.
the member states will furthermore be cooperating with one another in the interests of research by the european pharmaceutical industry and, ultimately, the health of their citizens, who will receive early treatment with the new products.

i de senere år er den europæiske medicinalindustris konkurrenceevne begyndt at sakke bagud i forhold til de amerikanske kolleger, selv om folkesundheden står stadig højere på dagsordenen for både medlemsstaterne og kommissionen.
in recent years the competi­tiveness of the european pharmaceutical industry has begun to fall behind its american counterparts while public health has rapidly moved up the agenda of both member states and the commission.

tingene må i den forbindelse ses i globalt perspektiv under særlig hensyn til de kommende medlemsstaters behov, forsknings - og udviklingsaktiviteterne i europa og den forskningsbaserede medicinalindustris stigende kompleksitet.
all this must be done in a global perspective, particularly looking at the needs of our future member states, research and development activities in europe and the increasing complexity of the research-based pharmaceutical industry.

det er en forbrydelse mod menneskeheden, da mere end 30.000 mennesker dør hver dag som ofre for den internationale medicinalindustris ublu produkter, fordi de ikke har adgang til medicin til bekæmpelse af større epidemier.
this is a crime against humanity, given that over 30 000 people die every day, as victims of the exorbitant products of the international pharmaceutical industry, because they do not have access to drugs to combat major epidemics.

alt i alt mener jeg, at meddelelsen sammen med de andre initiativer, jeg har nævnt, giver en ramme for at vende vores medicinalindustris konkurrenceevne, samtidig med at man styrker folkesundheden i europa.
overall, i believe the communication, together with the other initiatives i have mentioned, provides a framework for turning around the competitiveness of our pharmaceutical industry while reinforcing european public health.

samtidig med at det er fællesskabets opgave at sikre og styrke den europæiske medicinalindustris konkurrenceevne, skal der ved udvælgelsen af de midler, der skal anvendes til løsning af denne opgave, tages hensyn til de særlige forhold der gør sig gældende for denne industri.
thus, the community has to maintain and to reinforce the competitiveness of the european pharmaceutical industry.

den britiske medicinalindustris sammenslutning og sundhedsministeriet har i fællesskab udarbejdet et program for prisbegrænsninger, der gælder for alle virksomheder, der leverer lægemidler inden for rammerne af den offentlige sygesikring (nhs).
the british association of the pharmaceutical industry and the ministry of health have worked out a joint programme on price regulation applicable to all firms supplying drugs under the national health service (nhs).

aboim ingles (com). - (pt) hr. formand, forslaget til direktiv om prisbestemmelser for lægemidler og deres inddragelse under de nationale sygesikringsordninger er udarbejdet ud fra den overnationale medicinalindustris interesser.
van der lek (arc). — (nl) madam president, as mr metten has clearly stated, we are dealing here with a very special market in which the quantity of articles purchased is determined by the prescribing behaviour of the doctors, in which most of the costs are refunded by national systems and in which more over the patient is very often already in a dependent position, because the first concern of someone who is sick is not the cheapest way to get better.